Alzheimer's Institute of America brought infringement suit over Swedish mutation in bad faith, judge rules

By John O'Brien | Apr 6, 2015

PHILADELPHIA – Ruling that the Alzheimer’s Institute of America is not the patent-holder for a specific genetic mutation, a federal judge has decided it should have to pay the attorneys fees Avid Radiopharmaceuticals incurred in an infringement lawsuit between the two.

The Record Network